| 参考文献: |
1. Asamoto, M., et al., Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res, 2001. 61(12): p. 4693-700.
2. Asamoto, M., et al., Effects of genetic background on prostate and taste bud carcinogenesis due to SV40 T antigen expression under probasin gene promoter control. Carcinogenesis, 2002. 23(3): p. 463-7.
3. Cho, Y.M., et al., Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment. Cancer Sci, 2003. 94(2): p. 153-7.
4. Cho, Y.M., et al., Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model. Prostate Cancer Prostatic Dis, 2007.
5. Hokaiwado, N., et al., Lack of effect of human c-Ha-ras proto-oncogene overexpression on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats. Cancer Sci, 2003. 94(12): p. 1042-5.
6. Kandori, H., et al., Influence of atrazine administration and reduction of calorie intake on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats. Cancer Sci, 2005. 96(4): p. 221-6.
7. Said, M.M., et al., Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by leuprorelin, a luteinizing hormone-releasing hormone agonist. Cancer Sci, 2006. 97(6): p. 459-67.
8. Tang, M., et al., Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci, 2007. 98(4): p. 471-7. |